Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI: Safety Overview

Metric EZETIMIBE FAM-TRASTUZUMAB DERUXTECAN-NXKI
Total FAERS Reports 13,117 7,523
Deaths Reported 823 1,791
Death Rate 6.3% 23.8%
Hospitalizations 3,112 1,929
Average Patient Age 64.1 yrs 60.9 yrs
% Female Patients 51.7% 84.9%
FDA Approval Date Apr 26, 2019 N/A
Manufacturer A-S Medication Solutions N/A
Route ORAL N/A
Marketing Status Prescription Prescription